MedTrace Logo

Comparison of Vitamin K Doses in Patients With Larger Burn Injuries

NCT03941535 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-08-25

No results posted yet for this study

Summary

The use of Vitamin K in treating bleeding diatheses is well documented and accepted as standard of care, as is the effect of Vitamin K on calcium and bone metabolism. In the treatment of larger burns however, there is a paucity of available literature related to optimal daily dosing, goals of therapy and potential complications. This study aims to identify any potential issues arising from the administration of a standard of care dose in an historical cohort of subjects with larger burns to a prospective patient population given a decreasing dose during their intensive care unit (ICU) stay.

Conditions

  • Burns

Interventions

DRUG

Vitamin K

Administration of intravenous Vitamin K in doses of 10mg/day, 5mg/day or 2mg/day

Sponsors & Collaborators

  • Joseph M. Still Research Foundation, Inc.

    lead OTHER

Principal Investigators

  • Michael Quinn, MD · Joseph M. Still Research Foundation, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2022-10-31
Completion
2022-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941535 on ClinicalTrials.gov